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Abstract
As the human ovarian follicle enlarges in the course of a regular cycle or following controlled ovarian stimulation, the
changes in its structure reveal the oocyte environment composed of cumulus oophorus cells and the follicular fluid (FF).
In contrast to the dynamic nature of cells, the fluid compartment appears as a reservoir rich in biomolecules. In some
aspects, it is similar to the plasma, but it also exhibits differences that likely relate to its specific localization around the
oocyte. The chemical composition indicates that the follicular fluid is able to detect and buffer excessive amounts of
reactive oxygen species, employing a variety of antioxidants, some of them components of the intracellular milieu.
An important part is played by albumin through specific cysteine residues. But the fluid contains other molecules
whose cysteine residues may be involved in sensing and buffering the local oxidative conditions. How these molecules
are recruited and regulated to intervene such process is unknown but it is a critical issue in reproduction.
In fact, important proteins in the FF, that regulate follicle growth and oocyte quality, exhibit cysteine residues at specific
points, whose untoward oxidation would result in functional loss. Therefore, preservation of controlled oxidative
conditions in the FF is a requirement for the fine-tuned oocyte maturation process. In contrast, its disturbance enhances
the susceptibility to the establishment of reproductive disorders that would require the intervention of reproductive
medicine technology.
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Background
The ovarian follicle is the center of a complex network
of systemic and local signaling pathways [1–3] whereby
the follicle grows and the oocyte acquires maturity,
which is necessary for fertilization to occur and for a
viable embryo to develop.
This is a long process that in its early course does not ex-
hibit striking structural features, apart from enlargement of
oocyte volume and an increase in the number of its sur-
rounding cells. Then, a distinct cellular and liquid environ-
ment is established and encircles the evolving oocyte. It
consists mainly of cumulus oophorus (c.o.) cells and the
follicular fluid (FF), that occupies the antrum (Fig. 1a, b).
The complexity of the structural and functional changes
observed in this tissue, that comprises cells with different
lineages, and the remarkable mixture of biomolecules
present in the FF is by itself surprising. But, how the regu-
lation is carried out in order to result in ovulation of a
good quality oocyte, is extraordinary. The purpose of this
review is to focus on a part of this regulation.
The follicular microenvironment – Cumulus oophorus cells
C.o. cells are a structural feature of the antral follicle,
easily identifiable because they immediately envelope the
oocyte. Despite the difference in cell lineage, their ana-
tomical proximity and the mutual, paracrine actions they
perform [4, 5] have contributed to the establishment of
the concept of a single entity, designated cumulus oocyte
complex (COC).
The c.o. cells originate from the structurally homoge-
neous granulosa cell layers of the pre-antral follicles;
however, during follicle growth, they become function-
ally distinct from the mural granulosa cell counterparts
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as they exhibit different proliferative and steroid
secretory abilities, in an oocyte dependent manner [6].
In addition, c.o. cells have cytoplasmic extensions, whose
tips, upon protruding through the zona pellucida, make
direct contact with the oocyte cell membrane by way of
gap junctions [4]. In their molecular organization, small
calibre molecular channels connect both cytoplasms
across the intercellular space; however, while the chan-
nels limit the passage of large molecules, they allow the
small ones to flow and exert actions in the target cell. As
consequence, c.o. cells become the source of small
nutrients to the oocyte, as sugars, amino acids and nu-
cleotides [7], and they are also the origin of signal mole-
cules that regulate the progression of meiosis. Moreover,
c.o. cells supply the oocyte with reduced glutathione,
which is a major intracellular antioxidant [8, 9], and with
cysteine for additional glutathione synthesis [10]. C.o.
cells thus afford protection to the oocyte, notably from
oxidative stress [11, 12].
The communication c.o. cells/oocyte is not a one-way
communication. Indeed, the structural organization of
the COC allows transportation of molecules in both di-
rections, implying that signals originated in the oocyte
may interact with appropriate receptors on c.o. cells and
modulate their function. In fact, it was reported that
while removal of the oocyte from the COCs holds prolif-
erative and secretory abilities of c.o. cells, resuming the
contact with the oocyte resulted in the regaining of
those properties [6]. These and other previous findings
favoured the existence of diffusible oocyte secretory fac-
tors (OSFs) that act on the c.o. cells and modulate their
proliferative and secretory abilities [13, 14]. OSFs behave
as growth factors and include the growth differentiation
factor 9, GDF9, and the structurally related bone
morphogenetic protein 15 (BMP15, former GDF-9B),
members of the Transforming Growth Factor Beta
(TGFβ), superfamily [15]. Usually, this group of proteins
exhibits a set of seven conserved cysteine residues at the
mature region but both GDF-9 and BMP-15 have only
six residues of the seven-cysteine set; moreover, BMP15
contains two additional cysteine residues upstream of
the first conserved cysteine [16]. While, the absence of
one cysteine in GDF9 and BMP15 restrains their ability
to establish covalent binding and dimerize, their non-
covalent binding still results in functional homo or het-
erodimers [15]. Interestingly, the heterodimer arrange-
ment shows stronger biological activity compared to the
homodimers and appears to promote a different Type 1
and Type 2 TGFβ receptor assembly [17, 18].
The importance of these factors for normal follicle de-
velopment is high. The ovaries of Gdf9 knockout mice
have normal structure but the follicles do not develop
beyond the primary follicle stage [19] and granulosa cells
proliferative response is weaker [20]. Bmp15 knockout
female mice have ovulation disturbances and smaller
COCs [21].
Upon OSFs interaction with c.o. cell membrane recep-
tors, a transductive pathway is initiated, involving SMAD
factors [15, 22]. Following their translocation to the nu-
cleus, they function as transcription factors and activate
genes involved in c.o. cell proliferation [13] and glycoly-
sis for pyruvate production [23], extracellular matrix ex-
pansion [24], cholesterol synthesis [25] and intra-oocyte
glutathione level regulation [26].
OSFs are thought to be determinant for the establish-
ment of c.o. cells lineage, with implications to c.o. cells
proliferation and metabolism [27]. However, recent evi-
dence favors the existence of other determinants of c.o.
a b c
Fig. 1 Essential structure of the follicle and simplified overview of cumulus oophorus cell and oocyte interaction. a Advanced pre-antral stage follicle,
showing the two compartments: the antrum containing the follicular fluid (FF) and the cumulus oophorus (c.o.) cells around the oocyte.
b The magnification shows the relation of zona pellucida (z.p.) to the oocyte and the c.o. cells. C. granulosa cell natriuretic peptide type C (NAPC) interaction
with the c.o. cells NPR2 receptor that is promoted by oocyte secretory factors (OSFs) results in cGMP enhanced synthesis and its transport to oocytes along
the extensions of c. o. cells that protrude through the zona pellucida (ZP). In the oocyte, it blocks phosphodiesterase-3A, which maintains cAMP high and
the oocyte in prophase I arrest. Rabbit ovary. Bar in A and B: 100 μm
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cells distinct features as cell response may differ accord-
ing to the size of the follicle [28].
An important effect of OSFs is to promote c.o. cells
NPR2 receptor expression which, when activated by the
granulosa cell Natriuretic peptide type C, enhances c.o.
cells cyclic Guanosine Monophosphate (cGMP) synthe-
sis; in turn, cGMP is transported across the gap junc-
tions to the oocyte where it inhibits phosphodiesterase
3A and thus prevents cyclic Adenosine Monophosphate
(cAMP) hydrolysis. While cAMP level is high, the oocyte
is arrested in prophase I [29]; however, when LH surge
ensues, cGMP flow to the oocyte is blocked, which re-
sults in intra-oocyte drop of cAMP level and release of
the break on meiosis (Fig. 1c).
These fine-tuned c.o. cells actions, whose end-point is
successful fertilization, suggest that a change in their
structural arrangement around the oocyte or in their
function might be related to infertility. Indeed, the de-
scription of c.o. cells structural properties and the as-
signment of a quantitative score thereof, have been used
to predict fertilization ability [30] although the subjective
nature of the interpretation has posed natural accuracy
concerns [31].
The follicular microenvironment – Follicular Fluid
The presence of FF, the other component of the oocyte
microenvironment, is noticed early in the pre-antral
stage of the ovarian follicle when small, apparently
empty spaces appear between granulosa cells (Fig. 1a, b).
During the following months, as the follicles grow, to
reach 20 mm of diameter and more in the case the dom-
inant follicle stage is attained [1], the FF occupies a sin-
gle compartment that enlarges progressively until it
surrounds most of the c.o. cells and the oocyte.
The FF contains a complex mixture of steroids, metab-
olites, polysaccharides, proteins and small peptides, re-
active oxygen species (ROS) and antioxidant enzymes
[32, 33]. Probably, apart from acting directly as cellular
signals, the mutual interaction of many of these FF
molecules, or their absence, will also contribute to
appropriate follicular growth and oocyte maturation.
The identification of FF peptides and related proteins
has been the subject of intense research. In the last two
decades, the emergence of powerful techniques for pro-
tein analysis, as 2D PAGE combined with MALDI-MS
or liquid chromatography MS/MS, opened wide perspec-
tives for the study of the oocyte liquid environment by
identifying a large number of FF proteins.
Nearly 50% of FF proteins have extracellular origin;
most of the remaining proteins can be related to organ-
elles or other cell features; regarding their biological
activities, about 20% are enzymes, 14% are part of the
extracellular matrix or are involved in cell adhesion, and
another 16% include regulatory proteins as growth
factors, protease inhibitors, transcription factors and
other signaling related molecules [32]. Therefore, the FF
compartment has a remarkable diversity of biomole-
cules; however, the fact that many of the proteins are
enzymes, suggests that the compartment is not a mere
reservoir but also supports intense metabolic activity,
with impact on c.o. cells functioning and oocyte fate.
Angelucci et al. reported 695 different FF proteins or
peptides, of which 625 were common to plasma and 27 FF
additional proteins were considered absent from the
plasma [34]; these figures were enlarged to over 3700
peptides but only 480 proteins received firm identifi-
cation [32]. When these findings were combined with
previous data [34, 35] an impressive list of 789 dif-
ferent FF proteins was generated that included 64 FF
specific proteins [32].
Many of the identified proteins relate to biological pro-
cesses as acute response signaling, inflammation, coagula-
tion and complement cascades. In this respect, plasma
and FF seem indistinguishable [34–36], indicating that al-
though they are localized in distinct compartments, inter-
change between them exists. This is not unexpected
because there is a rich vascular network around the grow-
ing follicle [37] that favors plasma proteins movement
across the vessel walls into the FF compartment [38].
Whether some selectivity exists is controversial; while
some suggest it [38], others argue that there is no control
on the passage of molecules when ovulation approaches
[39], supporting the view that the process has similarities
with an inflammatory reaction [40].
The blood compartment is not the sole source of bio-
molecules to the FF because proteins also originate in
mural granulosa cells, the c.o. cells and the oocyte [7, 32].
Assuming that identification of new FF molecules will
continue, it is likely that other, low weight or low concen-
trated peptides will be identified in the future and, eventu-
ally, be ascribed to reproductive disorders.
The delicate nature of molecular interactions that fine
tune the COC functioning, as long as the follicle grows
until ovulation, requires an appropriate environment
that is thus provided by the local organization and inter-
action of c.o. cells and the FF. However, these players
have a profound difference: while cells are efficient and
adaptable entities, albeit small, the FF compartment is a
reservoir with limited versatility. So, to maintain a bal-
ance in a complex mixture of biomolecules, it is reason-
able to admit that important local chemical buffering
systems are required.
Redox reactions and their regulators are likely to fit
into this requirement. On the one hand, redox reactions
are at the foundation of cell metabolism and, therefore,
are a basic condition for life existence; in addition, their
regulated intervention is important for a variety of re-
productive processes and their dysregulation seems to
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contribute to reproductive disorders [41]. Furthermore,
important players involved in redox balance were identi-
fied in FF composition [34].
Oxidation and effects of oxidants on biomolecules.
Antioxidant balance
Among the oxidants that affect cell functioning, ROS
are compounds inevitably produced in the course of
cell metabolism. The primary oxidant is superoxide,
O2
•- (Fig. 2), that is rapidly dismutated by superoxide
dismutase (SOD) into hydrogen peroxide (H2O2).
Either by itself or upon conversion into more reactive
species, their continued production imposes an oxida-
tive burden on cells and harmful consequences in
biomolecules as sugars, nucleic acids, lipids and
proteins.
Briefly, polysaccharide oxidation results in polymerisa-
tion loss [42], the formation of advanced-glycation end
products (AGEs) when reacting with amino groups, and
further oxidation when AGEs interact with their recep-
tors [43]. In nucleic acids, ROS target their sugar moi-
eties, purines and pyrimidines, resulting in strand
breaks, base deamination or loss, and adduct formation.
Together with the failure of repair mechanisms, DNA
may be irreversibly damaged due to the establishment of
mutations and result in cell death. In lipids, the C = C
double bonds of unsaturated fatty acids are important
ROS targets; by continuously forming peroxyl radicals,
they extend the damage to nearby lipids, produce more
hydroperoxides and affect membrane structure and
functional properties.
Proteins are another category of biomolecules sub-
jected to oxidation. The effect of ROS on them is di-
verse, and relates to the intensity of the challenge, the
oxidized amino acids and the type of protein involved
[44]. Cysteine and methionine are very sensitive to oxi-
dation, but are amenable to revert on account of reduc-
tive enzymes [45]. A particularly important effect is
carbonylation which causes irreversible damage by ex-
posing hydrophobic residues previously buried in the
protein structure. All these changes lead to the un-
wanted state of oxidative stress, in which there are too
many ROS in relation to the available antioxidants [43].
Fortunately, organisms are endowed with intracellular
and extracellular antioxidants whose effect is to delay,
prevent or remove oxidative damage to a target mol-
ecule [46]. They may be enzymes, the most important of
which are SOD isoforms, catalase (CAT) and glutathione
peroxidase (GPx). The metalloenzyme SOD promotes
the dismutation of O2
•- to O2 and H2O2 and is consid-
ered the first defense line against ROS by way of three
mammalian isoforms: the cytosolic copper zinc SOD
(CuZnSOD or SOD1) [47], the mitochondrial manga-
nese SOD (MnSOD or SOD2) [48] and the extracellular
copper and zinc containing SOD (EC-SOD or SOD3)
[49]. The action of SOD enzymes results in enhanced
H2O2 production, controllable by CAT and GPx activity
[50]. CAT localizes mainly to peroxisomes, where they
convert H2O2 to water and molecular oxygen [51]. In
turn, there are four human GPx isoenzymes: the GPx1,
cytosolic and mitochondrial, the cytosolic GPx2, the
extracellular GPx3 and the phospholipid hydroperoxide
Fig. 2 Endogenous production of superoxide. Electrons generated in mitochondria, endoplasmic reticulum and cell membrane electron transport
chains, and oxidation catalyzed by a diversity of enzymes, partially reduce oxygen into superoxide anion (O2
• –,); this is dismutated by superoxide
dismutase (SOD) into O2 and H2O2; metal mediated catalysis of H2O2 originates the strongly reactive hydroxyl radical (HO
•). When targeting biomolecules,
the three oxidants, as well as many other resulting from the catalytic action of xanthine oxidase, cyclooxygenases and lipoxygenases, nitric oxide synthase,
norepinephrine breakdown and autoxidation processes, enlarge the diversity of oxidants and cause biomolecule damage (reviewed in ref. [43])
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GPx4 [52]. They neutralize H2O2 or organic peroxides
to water or alcohol, while converting reduced glutathi-
one (GSH) to oxidized glutathione (GSSG) [53].
In addition, other non-enzymatic antioxidant com-
pounds are endogenously synthesized or acquired from
the diet. Coenzyme Q10 (CoQ), uric acid (UA) and GSH
are examples of endogenous antioxidants. CoQ, which
also plays a central role in the mitochondrial respiratory
chain, is an antioxidant that prevents or neutralizes lipid
peroxyl radicals and regenerates vitamin E [54]. In
humans, UA acts as a strong scavenger of singlet oxygen
and hydroxyl radicals and is oxidized mainly to allantoin
[55]. Apart from its participation in enzymatic reactions,
GSH is a direct, potent scavenger of free radicals; it is
oxidized to GSSG and is subsequently reduced to GSH
by glutathione reductase, thus maintaining cellular sup-
ply of GSH [56]. Nutrient antioxidants include ascorbic
acid (vitamin C), naturally present in fresh vegetables
and in some mammals. Primates lack the enzyme that
catalyzes the last step in ascorbate synthesis [57]. The
biologically active form, L-ascorbic acid, is a strong re-
ducing agent that readily neutralizes free radicals and
harmful ROS, such as the hydroxyl radical, H2O2 and
singlet oxygen [58]. The fat-soluble alpha-tocopherol
(vitamin E) has high antioxidant potency, particularly as
cell membrane protector. It prevents lipid peroxidation
by scavenging peroxyl, oxygen and superoxide anion
radicals while converting itself to the alpha-tocopherol
radical that may be reduced back to its original form by
ascorbic acid, CoQ or other cellular reducing com-
pounds [59]. Folate is another important free radical
scavenger with antioxidant properties [60]. UA, ascor-
bate and tocopherol plasma levels are reflected in the
frequently used assay of the total antioxidant capacity,
TAC [61].
Follicular Fluid redox activity involvement in reproductive
modulation
ROS are usually considered harmful agents because their
effects modify the structure and functioning of biomole-
cules but some ROS are also useful signalling agents.
Hydrogen peroxide is at the centre of such processes.
Following early reports showing that H2O2 is required
for growth factor signal transduction [62], the scope of
ROS involvement in signalling increased. The multifa-
ceted reproductive system is an example of the expan-
sion of ROS physiological and regulatory roles to
folliculogenesis, oocyte maturation, luteal regression and
fertilization [41]. In fact, H2O2 appears to intermediate
crucial changes as is c. o. enlargement, that occurs
during the pre-ovulatory LH surge, which can be mim-
icked by the addition of H2O2 and is amenable to inhib-
ition by antioxidants [63]. Less clear is the limit between
signalling and unwanted or harmful consequences. In a
selected process as oocyte maturation, it was estimated
that 60 ng of ROS/oocyte maintains it in diplotene ar-
rest, whereas a moderate increase in ROS production to
80 ng/oocyte is able to resume meiosis [64].
It has been recognized that important targets of signal-
ling ROS are thiol groups of «free» cysteine residues,
not involved in the establishment of disulphide bonds
[65]; these are widespread at the surface of proteins and
may be oxidized rapidly, but reversibly, thus contributing
to attenuate the oxidative insult and to prevent its
spread along the entire protein [65]. The diversity of
modifications exhibited by oxidized cysteine thiol group
[66] is evidence of its versatility and ability to acquire
unique functional properties [67]. Such modifications,
apart from the simple disulfide bond formation, include
the glutathionylation and nitrosylation and other forms
of increasing thiol level of oxidation as are the sulfenic,
the sulfinic and the sulfonic acid modifications [66, 67].
Not all cysteine residues are regulatory targets [65, 68].
However, there is evidence that different categories of pro-
teins are susceptible to oxidation through cysteine thiol
groups and it is likely that different experimental condi-
tions will produce specific sets of intracellular or secreted
modified proteins [66, 67]. Susceptible proteins include
tyrosine phosphatases, proteases as caspases, adaptors and
chaperones as heat shock proteins, transcription factors as
the bacterial OxyR protein, p53, hypoxia-inducible factor,
redox modulator proteins, as thioredoxin and peroxire-
doxin, and other intracellular and extracellular pro-
teins as albumin, transthyretin, high-mobility group
protein box 1 (HMGB1), profilin and vimentin [66,
67]. As even non-active residues, may also be targeted
by oxidation, provided they are localized in a suscep-
tible position, it was estimated that >500 proteins are
in such condition [69], thus making the oxidation of
cysteine thiols a process with the potential to affect a
variety of biological functions.
In contrast to the intracellular compartment, extracellular
spaces such as plasma and FF compartments are oxidizing
environments that affect their contents and, in particular,
contribute to the diminished ratio of reduced cysteine. The
condition results in near absence of free cysteine [66] and
in the decrement of free thiols of the FF compartment,
which appears critical for the redox balance and has strong
implication to the reproductive outcome [70].
The exposure to an oxidative environment of the OSFs
BMP15 and GDF9 present in the FF suggests that the
thiols from cysteine residues at the pro-region are sus-
ceptible to oxidize. Although this event may prevent the
oxidation of the remaining molecule, it would do so at
the expense of the OSFs ability to dimerize or heterodi-
merize [17] and interact with their c.o. cells receptors,
which is a necessary step to promote COC development
and oocyte maturity.
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FF samples obtained from women upon controlled
ovarian stimulation contain common antioxidants as
SOD isoforms 1, 2 and 3, GPx, CAT, glutathione S-
transferase (GST), peroxiredoxins (Prx) and glutathione
reductase [32, 34, 35]. Beyond their presence, enzyme
activity was also detected [71, 72], favouring the exist-
ence of an ongoing antioxidation in the FF, eventually
intensified close to ovulation when follicles enlarge con-
siderably [73]. Other, important antioxidants as GSH,
vitamin E and SOD were assayed in the FF and their
levels were found to parallel serum levels [74]. These
findings further support the view that an effective com-
munication between FF and plasma compartments exists
and that understanding the redox regulatory mecha-
nisms in plasma will improve the knowledge on similar
mechanisms operating in FF.
Albumin, a major component of both the serum and
the FF, is well known for its role in osmotic regulation. In
addition, albumin has antioxidant properties. In fact, its
structure includes a cysteine in position 34, not engaged
in disulfide bonding, whose thiol group is able to react re-
versibly with oxidizing species; moreover, because of its
abundance, albumin behaves as antioxidant and oxidation
sensor [65]. Interestingly, although most serum and FF al-
bumin is detected in its reduced form, the relative concen-
tration of reduced albumin is higher in FF compared to
the serum [75] suggesting that FF albumin stands as an
important means to buffer oxidative conditions.
The level of reduced albumin in FF has positive repro-
ductive impact as antioxidant. In fact, FF samples associ-
ated to viable oocytes, exhibited significantly higher level
of reduced albumin, compared to FF samples surrounding
structurally degenerated oocytes, whose level of oxidized
albumin was higher [75]. Later in development, oxidation
in the FF maintains its relevance; it was reported that
oocytes resulting in low quality embryos, had been re-
trieved from FF containing higher H2O2 level, compared
to oocytes that resulted in high quality embryos [76].
Moreover, oxidized methionine and ubiquitinated proteins
were reported to be increased in FF from women whose
pregnancy was unsuccessful [77], further emphasizing the
irreversibility of the damaging effects of continued oxida-
tion [78] and the functional disability therein. Therefore,
enhanced oxidation in the FF results in lesser reproductive
success and, in fact, lower level of ROS and higher total
antioxidant capacity (TAC) were recognized as pregnancy
predictors for intracytoplasmic sperm injection [79].
Although much of the stress is attributed to in-
creased ROS production [80, 81], it is also consequent
to local decrement of antioxidant level. Higher FF
concentrations of vitamin E and beta carotene (and
ascorbic acid to a lesser extent) were associated with
better pregnancy outcome [82], whereas the level of
antioxidants was smaller in unexplained infertility and
other female reproductive disorders, when compared
to their healthy counterparts [82].
The reduction of plasma and FF level of vitamin E and
of beta carotene that accompanies the less successful re-
productive outcome, parallels the reduced antioxidant
scavenging properties reported in ageing. In the FF of re-
productively aged women, the SOD activity increased,
catalase and GST decreased and both GPx and GSSG-
Reductase exhibited a slight increase [72]; in addition, in
older women, there was a drop in the FF concentration
of hemopexin, which binds and clears the iron contain-
ing heme [83] and some evidence indicates that the re-
sponse to enhanced local oxidation is sluggish compared
to younger women [84]. Not surprisingly, culturing bo-
vine oocytes with FF from older animals, and containing
enhanced AGEs level, resulted in accelerated oocyte
nuclear maturation, enhanced ROS production and ab-
normal fertilization [85].
So, in parallel to the plasma, the complex mixture of
biomolecules present in the FF is indicative of their in-
volvement in multifaceted biological processes. We are
convinced that a part of them modulates the local oxida-
tive balance by way of the properties of their cysteine
residues. How the modulation is exerted or how the
molecules involved are recruited is essentially unknown
but is likely to aim at the provision of appropriate condi-
tions for oocytes to be fertilized. It is interesting that
when sensing environmental oxidative challenges, cells
activate thiol production mechanisms to buffer the im-
balance and regain homeostasis [84].
Reproductive disorders and perspective of antioxidant
intervention
An important part of the discussion about ROS effects
on cells relate to their ill-separated dual, harmful or sig-
naling, properties. Also difficult to verify is whether the
harmful effects of oxidation antedate well-known disor-
ders or a previously established disorder provides a
favorable field for oxidative harmful consequences. This
difficulty may underlie the controversies on the effects
of oxidation in the reproductive success [86–88].
As oxidation is harmful, it is reasonable to anticipate
that the administration of antioxidants will provide pro-
tection from excessive oxidation and health improvement.
Actually, while the provision of some antioxidants as nu-
tritional supplements to fulfil the recommended dietary
allowance (RDA) is beneficial in specific conditions as
childhood, pregnancy and perimenopause, their adminis-
tration in amount above RDA does not support, and
sometimes contradicts, what was reasonably expected.
In fact, consistent results indicate that mortality is sig-
nificantly increased when Beta-carotene, vitamin A and
vitamin E are administered in amount above the RDA
[89]. In addition, antioxidant supplementation with
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vitamin C, vitamin E or beta carotene did not offer over-
all benefits for the primary prevention of cancer inci-
dence or mortality [90] and, instead, they may have a
role in the establishment of colorectal cancer [91].
In the area of reproduction, polycystic ovarian syn-
drome (PCOS) and endometriosis, two major disorders
that limit reproductive outcome, have been related to
local unbalanced oxidation.
In c.o. cells from patients with PCOS, the ratios of
NAD+/NADH and NADP+/NADPH were higher, the
ratio of GSH/GSSH was lower and the mitochondrial
ROS production, assessed by the fluorescence emission
of 2′,7′-Dichlorofluorescein was higher, all suggesting
enhanced oxidative stress [92].
Endometriosis is another condition where, apart from
some controversy [93], enhanced oxidation was recog-
nized [41, 94–96]. In endometriosis, under the action of
the cyclical hormonal changes, an inflammatory reaction
is triggered in the proximity of ectopic endometrial cell
implants, resulting in attraction of inflammatory cells
that activate ROS production by NADPH oxidases. In
time, because the inflammatory reaction is cyclical, local
structural and functional abnormalities ensue.
In endometriosis, both the elevated ROS production
and the reduction of antioxidants were reported. In fact,
SOD and vitamin E levels in FF from women with endo-
metriosis were lower, and ROS were higher, compared to
controls [97]. In addition, the reduced GSH concentra-
tion found in endometriosis FF, compared to controls,
was also associated to inferior embryo quality [70].
Moreover, when FF samples from women with endo-
metriosis, who had unsuccessful implantation, were
compared with FF samples from women whose implant-
ation was successful, increased concentration of ROS,
nitric oxide and malonaldehyde was verified, in contrast
to other molecules involved in oxidative stress allevi-
ation [98]. Interestingly, FF albumin and hemopexin,
both implicated in oxidative burden mitigation, were
identified as distinct proteins in women with endometri-
osis who conceived, compared to women with endomet-
riosis who did not conceive [99]. These findings indicate
that the FF of endometriosis patients has insufficient
antioxidant capacity, likely as consequence of extensive
FF thiol groups oxidation [70].
Similarly, women whose diagnosis was tubal obstruc-
tion or mild tubal disorders and who had successful
pregnancies, showed lower concentration of oxidant
molecules in the FF when compared with cases of
unsuccessful pregnancy [98].
In view of the association of reduced FF antioxidant
capacity with diminished reproductive success, and ex-
perimental data favoring beneficial effects of antioxidant
administration [100], some studies addressed the effects
of antioxidant supplementation in humans.
It was reported that the administration of a micronu-
trient mixture (including vitamins C and E and folic
acid,) prior to FF collection, resulted in reduced oxida-
tion of FF components [101] and even increased FF
TAC, free thiol residues and the number of viable oo-
cytes [83]. In addition, vitamin C and E intake within
the RDA range, compared to intake bellow the RDA, re-
sulted in amelioration of fertilization rate and improve-
ment of early embryo structural fitness [102] and also in
a drop of FF myeloperoxidase assessed in women diag-
nosed with severe endometriosis [103]. Administration
of other compounds with antioxidant properties as folate
[104] or with D-chiro-inositol phosphoglycan [105]
resulted in decrement of FF homocysteine level and in
increased free thiol groups of FF proteins, respectively;
in both, improvement of oocyte quality was found. A
similar change in FF free thiols level was noticed in re-
productively aged women upon administration of a
micronutrient supplementation containing vitamins C
and E and folate [106].
In general, these results favor the existence of a benefi-
cial effect from the use of antioxidant supplementation.
However, limitations remain because of the number of
subjects enrolled in the studies and the difficulty to ver-
ify the precise amount of administered antioxidant.
Conclusions
Along approximately 3 months, local and systemic sig-
nals promote the growth of the ovarian follicle and the
establishment of a biomolecule rich fluid compartment.
The structural organization of the COC endows the FF
with the ability to supply the oocyte and c.o. cells with a
variety of compounds. Among these, the presence and
activity of important enzymatic and non-enzymatic anti-
oxidants reflects FF involvement in harmful ROS effects
prevention. Less clear is the role of ROS in local
biological processes regulation but, the FF volume and
rich composition in molecules that modulate redox reac-
tions, that is noticed in pre-ovulatory follicles, suggest
that they have a relevant intervention in oocyte growth
and maturation.
Current data indicates that an important part of anti-
oxidant buffering effect occurs upon engagement of spe-
cific cysteine residues that oxidize rapidly; in this sense,
such proteins behave as redox sensors [65], a view that
could be extended to albumin in FF because of its
abundance and its cysteine mediated antioxidant proper-
ties. For other, less concentrated FF proteins, one may
speculate that their cysteine residues exert similar roles
for self-protection and for local antioxidation. Thus,
similarly to the proposed contribution of the intracellu-
lar highly concentrated actin [107], cysteines in FF
proteins might work as sensors and then as buffers of
oxidative stress.
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This is an exciting and growing area of research
[108, 109]. In the particular field of reproduction, it
will provide additional knowledge of a critically regu-
lated set of steps, as is the oocyte maturation process,
whose main intervening growth factors are the
cysteine rich mature oocyte secretory factors BMP15
and GDF9.
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